Dual-Function Potentiation by PEG-BPEI Restores Activity of Carbapenems and Penicillins against Carbapenem-Resistant Enterobacteriaceae

• Published in: ACS infectious diseases Vol. 7; no. 6; pp. 1657 - 1665
• Main Authors: Panlilio, Hannah, Lam, Anh K, Heydarian, Neda, Haight, Tristan, Wouters, Cassandra L, Moen, Erika L, Rice, Charles V
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 11.06.2021
• Subjects: Carbapenem-Resistant Enterobacteriaceae - genetics; Carbapenems - pharmacology; Escherichia coli; Microbial Sensitivity Tests; Penicillins; meropenem; New Delhi metallo-β-lactamase (NDM-1); carbapenem-resistant Enterobacteriaceae (CRE); antibiotic resistance; imipenem; potentiator
• ISSN: 2373-8227; 2373-8227
• DOI: 10.1021/acsinfecdis.0c00863

The rise of life-threatening carbapenem-resistant Enterobacteriaceae (CRE) infections has become a critical medical threat. Some of the most dangerous CRE bacteria can produce enzymes that degrade a wide range of antibiotics, including carbapenems and β-lactams. Infections by CRE have a high mortality rate, and survivors can have severe morbidity from treatment with toxic last-resort antibiotics. CRE have mobile genetic elements that transfer resistance genes to other species. These bacteria also circulate throughout the healthcare system. The mobility and spread of CRE need to be curtailed, but these goals are impeded by having few agents that target a limited range of pathogenic CRE species. Against CRE possessing the metallo-β-lactamase NDM-1, Klebsiella pneumoniae ATCC BAA-2146 and Escherichia coli ATCC BAA-2452, the potentiation of meropenem and imipenem is possible with low-molecular weight branched polyethylenimine (600 Da BPEI) and its poly­(ethylene glycol) (PEG)­ylated derivative (PEG-BPEI) that has a low in vivo toxicity. The mechanism of action is elucidated with fluorescence assays of drug influx and isothermal calorimetry data showing the chelation of essential Zn2+ ions. These results suggested that 600 Da BPEI and PEG-BPEI may also improve the uptake of antibiotics and β-lactamase inhibitors. Indeed, the CRE E. coli strain is rendered susceptible to the combination of piperacillin and tazobactam. These results expand the possible utility of 600 Da BPEI potentiators, where previously we have demonstrated the ability to improve antibiotic efficacy against antibiotic resistant clinical isolates of Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis.